Mirae Asset Global Investments Portfolio holdings
AUM
$28.7B
1-Year Return
20.96%
This Quarter Return
+4.4%
1 Year Return
+20.96%
3 Year Return
+114.88%
5 Year Return
+202.83%
10 Year Return
+496.23%
AUM
$24.6B
AUM Growth
+$2.03B
(+9%)
Cap. Flow
+$1.25B
Cap. Flow
% of AUM
5.09%
Top 10 Holdings %
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$168M |
| 2 |
Apple
AAPL
|
$71.3M |
| 3 |
Microsoft
MSFT
|
$57.4M |
| 4 |
HDFC Bank
HDB
|
$44.6M |
| 5 |
Schwab US Dividend Equity ETF
SCHD
|
$40.5M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$83.3M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$81.2M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$43.3M |
| 4 |
Broadcom
AVGO
|
$42.7M |
| 5 |
Advanced Micro Devices
AMD
|
$37.7M |
Sector Composition
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 10.25% |
| 3 | Communication Services | 8.94% |
| 4 | Healthcare | 6.61% |
| 5 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Maplebear
CART
$11.9B
| $73.2K | ﹤0.01% |
1,734
-133
| -7% | -$5.61K |
|
1202
Burlington
BURL
$18.4B
| $72.9K | ﹤0.01% |
256
-2
| -0.8% | -$570 |
|
1203
IDEAYA Biosciences
IDYA
$2.38B
| $72.5K | ﹤0.01% |
2,880
-176
| -6% | -$4.43K |
|
1204
Urban Edge Properties
UE
$2.67B
| $72.4K | ﹤0.01% |
3,386
-1,226
| -27% | -$26.2K |
|
1205
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.5B
| $71.7K | ﹤0.01% |
2,246
+657
| +41% | +$21K |
|
1206
Four Corners Property Trust
FCPT
$2.73B
| $71K | ﹤0.01% |
2,586
-984
| -28% | -$27K |
|
1207
Acadia Realty Trust
AKR
$2.63B
| $70.5K | ﹤0.01% |
2,939
-1,066
| -27% | -$25.6K |
|
1208
Tarsus Pharmaceuticals
TARS
$2.43B
| $70.1K | ﹤0.01% |
1,274
-102
| -7% | -$5.61K |
|
1209
WESCO International
WCC
$10.7B
| $68.9K | ﹤0.01% |
386
-509
| -57% | -$90.9K |
|
1210
Ligand Pharmaceuticals
LGND
$3.25B
| $68.8K | ﹤0.01% |
630
-31
| -5% | -$3.39K |
|
1211
Apogee Therapeutics
APGE
$2.26B
| $68.7K | ﹤0.01% |
1,500
-128
| -8% | -$5.86K |
|
1212
Supernus Pharmaceuticals
SUPN
$2.58B
| $68.4K | ﹤0.01% |
1,840
-153
| -8% | -$5.69K |
|
1213
TD Synnex
SNX
$12.3B
| $68.4K | ﹤0.01% |
578
-831
| -59% | -$98.3K |
|
1214
CG Oncology
CGON
$2.52B
| $67.7K | ﹤0.01% |
+2,254
| New | +$67.7K |
|
|
AZPN
1215
DELISTED
Aspen Technology Inc
AZPN
| $67.5K | ﹤0.01% |
270
+151
| +127% | +$37.8K |
|
1216
LXP Industrial Trust
LXP
$2.71B
| $67.5K | ﹤0.01% |
8,214
-3,210
| -28% | -$26.4K |
|
1217
Geron
GERN
$893M
| $67.5K | ﹤0.01% |
20,144
-1,658
| -8% | -$5.55K |
|
1218
RPM International
RPM
$16.2B
| $67K | ﹤0.01% |
544
-995
| -65% | -$123K |
|
1219
ScottsMiracle-Gro
SMG
$3.64B
| $66.8K | ﹤0.01% |
1,012
-500
| -33% | -$33K |
|
1220
Mirum Pharmaceuticals
MIRM
$3.82B
| $66.5K | ﹤0.01% |
1,600
-125
| -7% | -$5.2K |
|
1221
Core & Main
CNM
$12.7B
| $66.3K | ﹤0.01% |
1,300
-723
| -36% | -$36.9K |
|
1222
PVH
PVH
$4.22B
| $65.9K | ﹤0.01% |
613
-53
| -8% | -$5.7K |
|
1223
Akero Therapeutics
AKRO
$3.58B
| $65.7K | ﹤0.01% |
2,326
-185
| -7% | -$5.23K |
|
1224
Wave Life Sciences
WVE
$1.32B
| $65.6K | ﹤0.01% |
5,082
+570
| +13% | +$7.35K |
|
|
SIXG
1225
Defiance Connective Technologies ETF
SIXG
$633M
| $65.1K | ﹤0.01% |
1,355
| – | – |
|